Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

0.95
Delayed Data
As of Sep 30
 +0.009 / +0.96%
Today’s Change
0.64
Today|||52-Week Range
1.97
-32.62%
Year-to-Date
No recent news for X T L Biopharmaceuticals Ltd.

Today’s Trading

Previous close0.94
Today’s open0.96
Day’s range0.95 - 0.96
Volume496
Average volume (3 months)31,020
Market cap$12.9M
Dividend yield--
Data as of 1:43pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-29.05%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book2.63

Competitors

 Today’s
change
Today’s
% change
BVXVBiondVax Pharmaceuti...0.000.00%
CYANCyanotech Corp0.000.00%
EVOKEvoke Pharma Inc+0.07+3.20%
ISRIsoRay Inc+0.01+1.90%
Data as of 3:59pm ET, 09/30/2016

Financials

Last reporting dateMarch 17, 2016
EPS forecast (this quarter)$0.00
Annual revenue (last year)$0.00
Annual profit (last year)-$3.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Joshua Levine
Chief Financial Officer
David Kestenbaum
Corporate headquarters
Raanana, Hamerkaz

Forecasts

Search for Jobs